Vnitr Lek 2005, 51(9):1011-1018

Carcinoid

V. Cempírková*, P. Havránek
Interní oddělení Nemocnice České Budějovice, a.s., České Budějovice, přednosta prim. MUDr. Pavel Havránek

The authors are reporting on two cases of carcinoid tumours, which represent very well the great extent of problems with these malignomas and are discussing diagnostic signs and some puzzles. The first case is an unusual one, with the thrombosis of lienal and portal vein, displaying the difficult and tedious investigation of both etiology and character of the growth. The second case represents the carcinoid syndrom as the cardiologist's primarily problem. The authors are discussing the possibilities of the treatment in the case of generalised disease.

Keywords: carcinoid; ovarian tumor; delayed diagnosis; heart disease

Received: November 29, 2004; Accepted: February 11, 2005; Published: September 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cempírková V, Havránek P. Carcinoid. Vnitr Lek. 2005;51(9):1011-1018.
Download citation

References

  1. Schettler G et al. Repetitorium praktického lékaře. Praha: Galén 1995: 815-816.
  2. Kiňová S, Ďuriš I, Kratochvílová E et al. Carcinoid tumors - somatostatine in diagnosis and therapy. Bratisl Lek Listy 2002; 103: 108-112. Go to PubMed...
  3. Chatterjee K, Heather JC. Carcinoid heart disease from primary ovarian carcinoid tumorous. A case report a review of literature. Am J Med 1968; 45: 643-681. Go to original source... Go to PubMed...
  4. Modlin IM, Lye KD, Kidd M. Decade Analysis of 13,715 Carcinoid Tumors. Cancer 2003; 97: 934-959. Go to original source... Go to PubMed...
  5. Davis KP, Hartmann LK, Keeney GL et al. Primary ovarian carcinoid tumoros. Gynecol Oncol 1996; 61: 259-265. Go to original source... Go to PubMed...
  6. Lamberts SW, Krenning EP, Klijn JG et al. The clinical use of somatostatin analoques in the treatment of cancer. Baillieres Clin Endocrinol Metab 1990; 4: 29-49. Go to original source... Go to PubMed...
  7. Nobin A, Mansson B, Lunderquist A. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour. Acta Oncol 1989; 28: 419-424. Go to original source... Go to PubMed...
  8. Klener P. Protinádorová chemoterapie. Praha: Galén 1996: 555-556.
  9. Lawrence JP, Ashizuka J, Haber B. The effect of somatostatin on 5-hydroxytryptamin release from carcinoid tumor. Surgery 1990; 108: 1131-1135. Go to PubMed...
  10. Crawford MH, Di Marco JP. Cardiology. 1st ed. London: Mosby 2001: 11-12.
  11. Ferri F. Practical Guide to the Care of the Medical Patient. 6th ed. St. Louis: Mosby 2004: 345-347.
  12. Abeloff MD. Clinical Oncology. 3rd ed. Philadelphia: Elsevier/Churchill Livingstone 2002: 1631-1636.
  13. Charlesworth NE, Vincent SB Sr. Pruritic Dermatoses: Overview of Etiology and Therapy. Am J Med 2002; 113: 25S-33S. Go to original source... Go to PubMed...
  14. Bouros D, Hatzakis K, Labrakis H et al. Association of Malignancy With Diaseases Causing Interstitial Pulmonary Changes, Reviews. Chest 2002; 121(4): 1278-1289. Go to original source... Go to PubMed...
  15. Calhoun K, Toth-Fejel S, Cheek J et al. Serum peptid profiles in patients with carcinoid tumors. Am J Surg 2003; 186: 28-31. Go to original source... Go to PubMed...
  16. Cokonis CD, Green JJ, Manders SM. Primary carcinoid tumor of the skin. J Am Acad Dermatol 2004; 51: S74-S76. Go to original source... Go to PubMed...
  17. Bhattacharya R, Rao S, Kowdley KV. Liver involvement in patients with solid tumors of non-hepatic origin. Clin Liver Dis 2002; 6: 1033-1043. Go to original source... Go to PubMed...
  18. Pandharipande PP, Reichard PS, Vallee MF. High gastric output as a perioperative sign of carcinoid syndrom. Anesthesiology 2002; 96: 755-756. Go to original source... Go to PubMed...
  19. Toth-Fejel S, Pommier RF. Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumors. Am J Surg 2004; 187: 575-579. Go to original source... Go to PubMed...
  20. Braunwald E. Heart Diasease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: Saunders 2001: 1692-1694.
  21. Kiňová S, Kováčová E, Bulas J et al. Výskyt karcinoidného syndromu u pacientov s karcinoidom. Vnitř Lék 2004; 50(2): 126-133. Go to PubMed...
  22. Collins N, Bellamy G, Hayes P. Intrapericardial carcinoid metastasis. J Am Soc Echocardiogr 2004; 17: 675-676. Go to original source... Go to PubMed...
  23. Ruszniewski P, Ducreux M, Chayvialle JA et al. Treatment of the carcinoid syndrom with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients. Gut 1996; 39: 279-283. Go to original source... Go to PubMed...
  24. Botero M, Fuchs R, Paulus DA et al. Carcinoid heart disease: a case report and literature review. J Clin Anesth 2002; 14: 57-63. Go to original source... Go to PubMed...
  25. Chaowalit N, Connolly HM, Schaff HV et al. Carcinoid heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol 2004; 93: 1314-1315. Go to original source... Go to PubMed...
  26. Šteiner I. Postižení srdce při karcinoidu. Čes Slov Patol 2003; 39: 55-58.
  27. Kiňová S, Ďuriš I. Carcinoid tumor. Bratisl Lek Listy 2001; 102: 495-504. Go to PubMed...
  28. Pellikka PA, Tajik AJ, Khandheria BK et al. Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188-1196. Go to original source... Go to PubMed...
  29. Larsen PR, Williams RH. Williams Textbook of Endocrinology. 10th ed. Philadelphia: Saunders 2002: 1857-1870.
  30. Rodriguez JA, Meyers MO, Jacome TH et al. Intraoperative Detection of a Bronchial Carcinoid with a Radiolabeled Somatostatin Analog. Chest 2002; 121: 985-988. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.